Insys Therapeutics (United States)

Insys Therapeutics was a specialty pharmaceutical company that developed Subsys (fentanyl sublingual spray) for breakthrough cancer pain. The company filed for bankruptcy following legal issues related to opioid marketing practices. Subsys continues to be available under other ownership for appropriate cancer pain patients.